Live Breaking News & Updates on Lancefield Groupb Streptococcus

Stay updated with breaking news from Lancefield groupb streptococcus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

MinervaX Announces Completion of Enrolment in Phase I Clinical Vaccine Trial as it Addresses the Global Burden of Group B Streptococcus in Older Adults

/PRNewswire/ MinervaX ApS, a privately held Danish biotechnology company developing a novel, prophylactic vaccine against Group B Streptococcus (GBS), has. ....

Lidia Oostvogels , Isabel Leroux Roels , Strategic Communications , Lancefield Groupb Streptococcus , Centre For Vaccinology , Ghent University , Groupb Streptococcus , Lund University , Minervax Aps , Chief Medical Officer , Principal Investigator , Chief Executive ,

MinervaX Commences First Phase 1 Clinical Study of Novel GBS Vaccine in Older Adults

/PRNewswire/ MinervaX ApS, a privately held Danish biotechnology company developing a novel vaccine against Group B Streptococcus (GBS), announces the first. ....

South Africa , United Kingdom , City Of , Lidia Oostvogels , Isabel Leroux Roels , Paul Heath , Centre For Vaccinology , Groupb Streptococcus , St George Vaccine Institute , Lund University , Lancefield Groupb Streptococcus , Minervax Aps , Chief Medical Officer , Principal Investigator , Older Adults , Vaccine Institute , Lead Investigator ,